-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-TIVDAK® (Tisotumab Vedotin) Approved By Japan Ministry Of Health, Labour And Welfare For Treatment Of Advanced Or Recurrent Cervical Cancer That Has Progressed On Or After Chemotherapy

Reuters·03/27/2025 12:27:45

Please log in to view news